Damaira Pharmaceuticals Pvt Ltd

Meropenem is indicated for all age group including infants above 3 months of age as single agent therapy for the treatment of the following infections when caused by susceptible isolates of the designated microorganisms: Pneumonias and Nosocomial Pneumonias Urinary Tract Infections Intra-abdominal Infect...

Biapenem is a trusted broad - spectrum antibiotic for healthcare professionals with proven clinical effectiveness.it is well - suited therapy for various infections, including those caused by multidrug - resistant bacteria. it ensures optimal patient care and successful treatment outcomes.

Doripenem is an exceptional antibiotic which is effective against complicated infections which offers broad - spectrum coverage and reliable treatment outcomes.

Doripenem is an indispensable tool for healthcare providers that combat a wide array of infectious diseases.

Damaira Pharmaceuticals Pvt. Ltd., a state-of-the-art facility with WHO GMP accreditation, marking a significant milestone in our commitment to excellence.Our dedicated finished carbapenem manufacturing facility produces a range of superior quality injectables.

We are looking for esteemed organization of various countries to partner.

Our Finished Carbapenem Product Line:
Meropenem for Injection 1 gm (COPP & Dossier Available)
Meropenem for Injection 500 mg (COPP & Dossier Available)
Imipenem Cilastatin for Infusion 500 mg + 500 mg (COPP & Dossier Available)  

Each product undergoes rigorous testing and meets the highest quality control standards to ensure safety, efficacy, and reliability.

Yours Sincerely
Ankur Sharma
General Manager
Contact No.: 0091 99 151515 41 (Also on WhatsApp)